Navigation Links
Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
Date:5/21/2008

dies include:

-- A wide-ranging review of the outcomes of cryoablation in 2,558 primary

prostate cancer patients showed efficacy of cryoablation in terms of

biochemical survival and low morbidity. The average age of the

patients, all part of the nationwide Cryo-On-Line Database (COLD)

Registry, was 70 years and 419 of the patients had more than five years

of follow-up.

-- A 10-year, retrospective review of 78 patients at the University of

Texas M.D. Anderson Cancer Center demonstrated the effectiveness of

cryoablation for prostate cancer patients whose cancer returned after

being originally treated with radiation. After 10 years, more than 80

percent of the patients were disease free after cryoablation and the

investigators concluded that salvage cryoablation is curative in

approximately one-third of patients at 10-year follow up.

-- The first, multi-center study of focal, or partial gland, cryoablation

for 341 prostate cancer patients demonstrated that more than half of

the patients who were potent before the therapy were again potent after

six months, and more than 74 percent resumed potency within 36 months.

Focal cryoablation is designed to destroy the tumors in the prostate

while sparing the nerves to retain potency. These patients are also

part of the COLD Registry.

-- An 88-patient Cleveland Clinic study of the long term disease-free

survival rates (more than five years) of kidney cancer patients showed

that laparoscopic kidney cryoablation is an effective treatment in

select patients. The investigators determined that cancer-specific

survival of 95 percent is possible at five years and 88 percent is

possible at 10 years.

-- Six AUA-sponsored courses and workshops related to cryoablation

focused on prostate ultrasound, abdomi
'/>"/>

SOURCE Endocare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
2. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
5. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
6. Tapestry Announces Strategy to Focus on TPI 287 Clinical Program
7. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
8. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
9. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
10. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
11. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "Market ... and Europe" report to their offering. ,     ... analysis of the respiratory imaging diagnostics market in ... Europe . The service provides ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... devices worldwide, announced today its selected unaudited financial results for ... Highlights for Second Quarter 2011 ... 21.2% over the second quarter of 2010. Robust ...
... Pharmaceutical Company ("the Company," "K-V") (NYSE: KVa/KVb) today announced ... of assets of Nesher Pharmaceuticals, Inc. ("Nesher"), the Company,s ... assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals ... sales price for the transaction is $60 million (subject ...
Cached Medicine Technology:Mindray Announces Second Quarter 2011 Financial Results 2Mindray Announces Second Quarter 2011 Financial Results 3Mindray Announces Second Quarter 2011 Financial Results 4Mindray Announces Second Quarter 2011 Financial Results 5Mindray Announces Second Quarter 2011 Financial Results 6Mindray Announces Second Quarter 2011 Financial Results 7Mindray Announces Second Quarter 2011 Financial Results 8Mindray Announces Second Quarter 2011 Financial Results 9Mindray Announces Second Quarter 2011 Financial Results 10Mindray Announces Second Quarter 2011 Financial Results 11Mindray Announces Second Quarter 2011 Financial Results 12Mindray Announces Second Quarter 2011 Financial Results 13Mindray Announces Second Quarter 2011 Financial Results 14Mindray Announces Second Quarter 2011 Financial Results 15Mindray Announces Second Quarter 2011 Financial Results 16Mindray Announces Second Quarter 2011 Financial Results 17K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 2K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 3K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 4K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 5K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 6K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 7K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 8
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific ... compliance issues that may have raised the risk of ... just posted an article on the research. Click ... found airborne asbestos levels well above OSHA safety guidelines ... 2011. , “Asbestos compliance sampling data associated with the ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ProPin is ... Final Cut Pro X. Utilize ProPin to pin point locations ... given scene. , ProPin allows users to choose from ... in FCPX. With on-screen controls, video editors can easily manipulate ... to pin and mark with absolute ease. , Using ProPin is ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... D.C. (PRWEB) May 23, 2015 On ... of powers of a youngster's yogic power learned through ... Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, a ... more than 50 high profile professionals attending the 2015 ... by reading fluently -- blindfolded. , In a ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... November 6 - Elsevier Signs Agreement ... that major global healthcare company, Bayer,HealthCare AG, headquartered ... EMBASE Classic. Available in electronic format for,the first ... database,drawn from 43 Excerpta Medica Abstract Journals published ...
... book geared to genetic blueprints from Elite Books, TUCSON, ... gene. It,plays a key role in the development of Alzheimer,s ... And it is greatly affected,by diet. In her seminal ... Weight, Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, ...
... Former Congressman,Henry J. Hyde was among eight people ... the Presidential Medal of Freedom. President Bush said,that ... of Mr. Hyde,s 32 years,of public service., ... Rehabilitation,Hospital where he is currently receiving medical rehabilitation ...
... 5 Epeius Biotechnologies,Corporation announced today that the company ... lead product with the opening of a Phase II,Registration ... the accelerated approval of Rexin-G for the treatment of ... in the Philippines, Epeius,opened a number of Phase I/II ...
... QED International Associates Inc,administrator for the HealthShares(TM) ... today announced that effective at the,opening of trading ... BSMD ) will replace Kyphon INC. (Nasdaq: ... The Corin Group (LSE: CRG.L) will,replace KYPH in ...
... 5 Hooper Holmes,Inc. (AMEX: HH ) today announced ... Inc. (Nasdaq: NABI ), has been,reappointed to the Company,s ... Board from 2005 to 2006. He replaces Paul Kolacki who,retired ... respect Les, and we are pleased to welcome him back ...
Cached Medicine News:Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 3Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 2Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 3Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 2Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 3
... temporary internal drainage from the ureteropelvic junction ... stricture. The segment with no sideports prevents ... preventing ingrowth of the ureteral wall to ... Intended for one-time use. CAUTION: Periodic evaluation ...
Since first designed by Dr. Roy P. Finney in 1978, ACMI™ Classic Ureteral Stents remain the standard for comfort, performance, and quality....
... retrograde or antegrade ureteral ... stent placement. The RB ... band on the delivery ... fluoroscopic visualization during placement. ...
... Used for interoperative placement to ... conduit construction and continent urinary ... packages. Intended for one-time use. ... stent must not remain indwelling ...
Medicine Products: